High level antibodies to TORCH in the IVIG preparation from Taiwanese

Chou, Ya-Hui; Hsieh, Kao-Hsian; Perng, Cherng‐Lih; Fan, Hueng-Chuen; Tien, Chiung‐Hsi; Wang, Chih‐Chien; Chen, Shyi-Jou

doi:10.1097/jcma.0000000000000043

Cited by 4 publications

(3 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While there is no clear evidence regarding their efficacy for monkeypox infection during pregnancy, the use of immune globulins has been widely documented in other diseases during pregnancy, verifying their safety and efficacy. 38 …”

Section: Recommendations For Diagnosing and Treating Monkeypox During...mentioning

confidence: 99%

Mpox and pregnancy: A neglected disease and its impact on perinatal health

Velázquez-Cervantes

Ulloa-Aguilar

León-Juárez

2023

Revista Clínica Española (English Edition)

View full text Add to dashboard Cite

Section: Recommendations For Diagnosing and Treating Monkeypox During...mentioning

confidence: 99%

Mpox and pregnancy: A neglected disease and its impact on perinatal health

Velázquez-Cervantes

Ulloa-Aguilar

León-Juárez

2023

Revista Clínica Española (English Edition)

View full text Add to dashboard Cite

“…Otra opción podría ser la administración de inmunoglobulinas de vaccinia, un cóctel de anticuerpos purificados de individuos inmunizados con la vacuna de la viruela humana. Aunque no hay evidencias claras de su efectividad para la infección con la viruela del mono durante el embarazo, sí se ha documentado extensamente la administración de inmunoglobulinas para otras enfermedades durante el embarazo, constatando su seguridad y su eficacia 38 .…”

Section: Recomendaciones Para Diagnosticar Y Tratar La Viruela Del Mo...unclassified

La viruela del mono y el embarazo: una enfermedad olvidada y su impacto en la salud perinatal

Velázquez-Cervantes¹,

Ulloa-Aguilar²,

León-Juárez³

2023

Revista Clínica Española

View full text Add to dashboard Cite

“…They demonstrated decreased microglial activation, reduction in complement component 3 (C3) levels, breakdown of blood‑brain barrier, and spontaneous seizures [ 89 ]. In humans, the current literature consists of retrospective case reports regarding the use of IVIG for status epilepticus in the general population [ 90 , 91 ]. Despite the lack of literature in the pregnant population, its safety profile in pregnancy suggests there is no reason to withhold IVIG in pregnant patients in status epilepticus.…”

Section: Medical and Surgical Managementmentioning

confidence: 99%

Neurocritical Care of the Pregnant Patient

Malaiyandi

James

Peglar

et al. 2021

Curr Treat Options Neurol

View full text Add to dashboard Cite

Purpose of review To summarize recent changes in management and emerging therapies for pregnant neurocritical care patients. Recent findings Diagnostic and treatment options for managing neurologic emergencies in pregnant patients have expanded with both greater understanding of the effects of imaging modalities and medications on pregnancy and application of standard treatments for non-pregnant patients to pregnant populations. Specifically, this includes cerebrovascular diseases (pregnancy-associated ischemic stroke, pregnancy-associated intracerebral hemorrhage, cerebral venous sinus thrombosis), post-maternal cardiac arrest care, seizures and status epilepticus, myasthenia gravis, and fetal somatic support in maternal death by neurologic criteria. Summary With the exception of direct abdominal computed tomography (CT), most imaging studies are reasonably safe in pregnancy. When emergent imaging is needed to prevent maternal morbidity or mortality, any CT sequence with or without contrast is appropriate to pursue. Though new safety data on antiplatelets, antihypertensives, thrombolytics, and antiepileptic drugs have increased options for disease management in pregnancy, unfractionated and low-molecular weight heparin remain the safest options for anticoagulation. Early studies on hypothermia, ketamine, and immunomodulating therapies in pregnancy are promising. In myasthenia gravis, new data on adjunct devices may allow more patients to undergo safe vaginal delivery, avoiding cesarean section and the associated risk of crisis. When difficult decisions regarding preterm delivery arise, recent outcome studies can help inform discussion. Lastly, when the feared complication of maternal death by neurologic criteria occurs, fetal somatic support may help to save at least one life.

show abstract

High level antibodies to TORCH in the IVIG preparation from Taiwanese

Cited by 4 publications

References 38 publications

Mpox and pregnancy: A neglected disease and its impact on perinatal health

Mpox and pregnancy: A neglected disease and its impact on perinatal health

La viruela del mono y el embarazo: una enfermedad olvidada y su impacto en la salud perinatal

Neurocritical Care of the Pregnant Patient

Contact Info

Product

Resources

About